AML MRD Flow Panel

Flow Cytometry

MRD assessment has the potential to improve outcomes for patients with acute myeloid leukemia (AML). This assay is available as a Global test only and is designed to detect MRD at a sensitivity level of 0.01%.

Turnaround time

24 Hours

Level of Service

Global

New York Approved: Yes

Specimen Requirements

Bone marrow aspirate: 2-3 mL, first pull. EDTA preferred. Sodium heparin tube acceptable.
Lithium heparin or ACD (pale yellow/no gel separator) not acceptable. Please provide recent CBC report.
NY Clients: Please provide Date and Time of Collection.

Storage and Transportation

Specimens should be received at NeoGenomics within 72 hours from collection to assure sample integrity and acceptable cell viability. Note: New York State samples must be received within 48 hours from collection per NYS requirements. Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.

CPT Code(s)*

88184x1, 88185x19. Add 88189x1 for Global

*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.

Biomarkers

Flow Cytometry

Markers
CD4	CD87	CD371	CD117	CD19	CD11b
CD34	CD13	CD14	CD16	CD33	CD64
HLA-DR	CD38	CD2	CD56	CD7	CD15
CD65	CD45

Last Updated: February 18, 2026

Get in touch

Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.